Conference
ASSESSMENT OF THE COST UTILITY OF PALIVIZUMAB FOR PREVENTING SEVERE RESPIRATORY SYNCYTIAL VIRUS (RSV) INFECTION IN PRETERM INFANTS BORN 29-35 WEEKS' GESTATIONAL AGE IN THE PHILIPPINES
Authors
Del Rosario-Famadico S; Carbonell-Estrany X; Paes B; Tarride J-E; Rodgers-Gray B; Keary I; Fullarton J
Volume
28
Publisher
ELSEVIER SCIENCE INC
Publication Date
December 1, 2025
Conference proceedings
VALUE IN HEALTH
Issue
12
ISSN
1098-3015